WallStreetZenWallStreetZen

NASDAQ: HQY
Healthequity Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HQY

Based on 9 analysts offering 12 month price targets for Healthequity Inc

Min Forecast
$100.00+1.33%
Avg Forecast
$111.67+13.15%
Max Forecast
$128.00+29.7%

Should I buy or sell HQY stock?

Based on 9 analysts offering ratings for Healthequity Inc.

Strong Buy
Strong Buy
4 analysts 44.44%
Buy
5 analysts 55.56%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HQY's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HQY as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their HQY stock forecasts and price targets.

HQY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-03
lockedlocked$00.00+00.00%2026-06-01
lockedlocked$00.00+00.00%2026-05-22
lockedlocked$00.00+00.00%2026-04-09
lockedlocked$00.00+00.00%2026-03-19Find Out Why
JP Morgan
Top 20%
81
Strong BuyMaintains$123.00+24.63%2026-03-18
RBC Capital
Top 30%
71
BuyMaintains$100.00+1.33%2026-03-18
Barclays
Top 24%
77
Strong BuyMaintains$110.00+11.46%2026-02-18
BTIG
Top 15%
86
Strong BuyMaintains$110.00+11.46%2026-02-17

1 of 1

Forecast return on equity

Is HQY forecast to generate an efficient return?

Company
24.87%
Industry
22.95%
Market
171.14%
HQY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HQY forecast to generate an efficient return on assets?

Company
15.4%
Industry
16.7%
HQY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HQY earnings per share forecast

What is HQY's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
$4.77+77.17%
Avg 2 year Forecast
$5.52+105.25%
Avg 3 year Forecast
$5.97+121.9%
HQY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HQY revenue forecast

What is HQY's revenue in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
$1.4B+6.94%
Avg 2 year Forecast
$1.5B+15.61%
Avg 3 year Forecast
$1.6B+23.02%
HQY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HQY earnings growth forecast

How is HQY forecast to perform vs Health Information Services companies and vs the US market?

Company
27.34%
Industry
25.34%
Market
34.17%
HQY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HQY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HQY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HQY revenue growth forecast

How is HQY forecast to perform vs Health Information Services companies and vs the US market?

Company
5.3%
Industry
7.69%
Market
13.96%
HQY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HQY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HQY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HQY$98.69$111.67+13.15%Strong Buy
TEM$53.59$66.82+24.68%Buy
HNGE$85.98$80.57-6.29%Strong Buy
TXG$44.48$31.64-28.88%Buy
MMED$15.88$21.20+33.50%Strong Buy
View Top Health Information Service Stocks

Healthequity Stock Forecast FAQ

Is Healthequity Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: HQY) stock is to Strong Buy HQY stock.

Out of 9 analysts, 4 (44.44%) are recommending HQY as a Strong Buy, 5 (55.56%) are recommending HQY as a Buy, 0 (0%) are recommending HQY as a Hold, 0 (0%) are recommending HQY as a Sell, and 0 (0%) are recommending HQY as a Strong Sell.

If you're new to stock investing, here's how to buy Healthequity stock.

What is HQY's earnings growth forecast for 2027-2029?

(NASDAQ: HQY) Healthequity's forecast annual earnings growth rate of 27.34% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 25.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.

Healthequity's earnings in 2026 is $230,704,000.On average, 17 Wall Street analysts forecast HQY's earnings for 2027 to be $398,431,160, with the lowest HQY earnings forecast at $381,794,331, and the highest HQY earnings forecast at $423,988,339. On average, 17 Wall Street analysts forecast HQY's earnings for 2028 to be $461,592,589, with the lowest HQY earnings forecast at $421,940,086, and the highest HQY earnings forecast at $519,671,008.

In 2029, HQY is forecast to generate $499,029,635 in earnings, with the lowest earnings forecast at $467,820,950 and the highest earnings forecast at $550,394,801.

What is HQY's revenue growth forecast for 2027-2029?

(NASDAQ: HQY) Healthequity's forecast annual revenue growth rate of 5.3% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.96%.

Healthequity's revenue in 2026 is $1,337,226,000.On average, 17 Wall Street analysts forecast HQY's revenue for 2027 to be $119,551,084,510, with the lowest HQY revenue forecast at $115,538,180,974, and the highest HQY revenue forecast at $124,734,418,244. On average, 17 Wall Street analysts forecast HQY's revenue for 2028 to be $129,248,934,722, with the lowest HQY revenue forecast at $120,888,719,022, and the highest HQY revenue forecast at $139,030,387,091.

In 2029, HQY is forecast to generate $137,525,548,265 in revenue, with the lowest revenue forecast at $130,168,558,449 and the highest revenue forecast at $145,802,161,808.

What is HQY's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: HQY) forecast ROA is 15.4%, which is lower than the forecast US Health Information Services industry average of 16.7%.

What is HQY's Price Target?

According to 9 Wall Street analysts that have issued a 1 year HQY price target, the average HQY price target is $111.67, with the highest HQY stock price forecast at $128.00 and the lowest HQY stock price forecast at $100.00.

On average, Wall Street analysts predict that Healthequity's share price could reach $111.67 by Jun 3, 2027. The average Healthequity stock price prediction forecasts a potential upside of 13.15% from the current HQY share price of $98.69.

What is HQY's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: HQY) Healthequity's current Earnings Per Share (EPS) is $2.69. On average, analysts forecast that HQY's EPS will be $4.77 for 2027, with the lowest EPS forecast at $4.57, and the highest EPS forecast at $5.07. On average, analysts forecast that HQY's EPS will be $5.52 for 2028, with the lowest EPS forecast at $5.05, and the highest EPS forecast at $6.22. In 2029, HQY's EPS is forecast to hit $5.97 (min: $5.60, max: $6.58).

What is HQY's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: HQY) forecast ROE is 24.87%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.